Prostate Cancer - Results from #60

Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing. June 10, 2022

Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. June 10, 2022

The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High Risk Prostate Cancer: A Validation Study from NRG/RTOG 0521. June 10, 2022

The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups. June 10, 2022

Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach June 9, 2022

Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy. June 9, 2022

Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings. June 9, 2022

Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer. June 9, 2022

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. June 9, 2022

The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer. June 9, 2022

Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate. June 8, 2022

Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay. June 8, 2022

Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial). June 8, 2022

External beam radiation therapy treatment factors prognostic of biochemical failure free survival: a multi-institutional retrospective study for prostate cancer. June 8, 2022

Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy. June 8, 2022

The survival outcomes of very young and elderly patients with high-risk prostate cancer after radical treatments: A population-matched study. June 7, 2022

Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis. June 7, 2022

[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]. June 7, 2022

Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy. June 7, 2022

Diagnostic value of multiparametric MRI in detecting residual or recurrent prostate cancer after high-intensity focused ultrasound. June 7, 2022

Page 4 of 1230

email news signup